Furthermore, SOX9 was found to be highly expressed in BCa patient tumors relative to normal tissue and showed strongest expression in ERα− tumors [39], and elevated SOX9 levels correlate with disease progression in PCa [34]. The gene discussed is SOX9; the disease is posterior cortical atrophy.